The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 clinical trial of regorafenib in patients with advanced pretreated melanoma (RegoMel).
 
Iris Dirven
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pierre Fabre
 
Manon Vounckx
No Relationships to Disclose
 
Jolien Isabel Kessels
Honoraria - Bristol-Myers Squibb Belgium
Consulting or Advisory Role - La Roche Posay
Travel, Accommodations, Expenses - Novartis; Sanofi/Regeneron
 
Nathalie Vanlaer
No Relationships to Disclose
 
Berlinde von Kemp
No Relationships to Disclose
 
Giuseppe Fasolino
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Abbvie
 
Bart Neyns
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pierre Fabre